A kind of preparation method of candesartan cilexetil tablet

A technology for candesartan medoxomil and sartan medoxomil tablets, which are applied in the directions of non-active ingredient medical preparations, medical preparations containing active ingredients, and pill delivery, etc., can solve the problems of decreased drug stability, decreased dissolution rate, Unfavorable commercial production and other issues

Active Publication Date: 2021-05-11
HINYE PHARM CO LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in actual production, when the particle size of candesartan cilexetil is reduced below 20 μm, the stability of the drug will be greatly reduced. In order to ensure its stability, it is necessary to add more low-melting oily substances, although The melted oily substance reduces the friction between the fine crystals and improves the stability of the product, but it will also lead to a decrease in the dissolution rate of the product, and it will also cause sticking problems in the subsequent tablet production process, which will lead to unsatisfactory one-sidedness. Smooth, affects the appearance of the product, and is not conducive to commercial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of candesartan cilexetil tablet
  • A kind of preparation method of candesartan cilexetil tablet
  • A kind of preparation method of candesartan cilexetil tablet

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] A preparation method of candesartan cilexetil tablet, comprising the following steps;

[0032] (1) Weighing and preparing materials: weighing and preparing materials according to the prescription ratio in the table below;

[0033]

[0034] (2) Preparation method;

[0035] The candesartan cilexetil, lactose, cornstarch, hydroxypropyl cellulose, and carmellose calcium that were taken by weighing the prescription amount were passed through a 50-mesh sieve three times using a swinging granulator, and were used for subsequent use; the polyethylene glycol 6000 dissolved in the prescription amount In 95% ethanol, stir and control the temperature in a water bath of 50-60°C, heat and dissolve to prepare a wetting agent for later use; place the sieved and mixed raw and auxiliary materials in a granulator for dry mixing for 5 minutes, and set the stirring speed of the granulator to 160rpm, the shear rate is 1500rpm. Then add a 95% ethanol solution of polyethylene glycol 6000 ...

Embodiment 2

[0037] The candesartan cilexetil tablets prepared by different prescriptions in Example 1 were placed at 60°C for 10 days, and a high temperature experiment was carried out to investigate the related substances of the product. The experimental results are as follows:

[0038]

[0039] According to the measurement results, it can be known that the product produced by the preparation method of the present invention, when the ratio of the dosage of candesartan cilexetil and polyethylene glycol 6000 in the prescription is 2:1, the related substances in the product are relatively higher than the related substances in other prescriptions. is the most stable.

Embodiment 3

[0041]Press 2015 version " Chinese Pharmacopoeia " four general rules 0931 dissolution rate and release rate determination method second method, measure the dissolution rate of different prescription products in embodiment 1, wherein dissolution medium: 1% polysorbate 20 aqueous solution 900ml, rotating speed: 50rpm, The measurement results are as follows;

[0042]

[0043] In the prior art, on the one hand, the addition of polyethylene glycol 6000 can improve the stability of the medicinal ingredients in the solid preparation, but on the other hand, it will also lead to a decrease in the disintegration of the solid preparation, so that the drug can be released from the solid preparation. Dissolution properties were significantly reduced. According to the above measurement results, it can be known that the addition of polyethylene glycol 6000 has little effect on the dissolution rate of the product by adopting the preparation method of the present invention, and does not ca...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention relates to a preparation method of candesartan cilexetil tablets, which comprises weighing candesartan cilexetil, lactose, corn starch, hypromellose, and carmellose calcium, and passing them together through a 50-mesh granulator using a swinging granulator. Sieve and mix, standby; wherein the weight ratio of candesartan cilexetil and polyethylene glycol 6000 is 4:1-4:2; the weight ratio of hypromellose and carmellose calcium is 7:0.4-7:1 ; Weigh polyethylene glycol 6000 and add it to 95% ethanol, stir and control the temperature in a water bath at 50-60°C, heat and dissolve to prepare a wetting agent for later use; wherein the weight ratio of polyethylene glycol 6000 to 95% ethanol is 1:6.5- 1:13; the sieved and mixed material is placed in a horizontal wet mixing granulator for dry mixing, and the prepared wetting agent is added at a liquid addition rate of 7-8kg / min for granulation, and the wet mixing time is 4 After ‑6 minutes, the material is discharged, and the wet granules are sized on a swing granulator with a 24-mesh stainless steel sieve; and other processes such as drying and tableting are carried out.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a preparation method of candesartan cilexetil tablets. [0002] technical background [0003] Candesartan cilexetil is rapidly hydrolyzed into the active metabolite candesartan in the body. Candesartan is a selective angiotensin II receptor (AT1) antagonist that antagonizes vascular tension by binding to vascular smooth muscle AT1 receptors The vasoconstriction effect of factor Ⅱ, thereby reducing the resistance of peripheral blood vessels, helps to lower blood pressure. It is also believed that candesartan can exert a certain antihypertensive effect by inhibiting the secretion of aldosterone by the adrenal gland. Candesartan does not inhibit kininase II and does not affect the degradation of bradykinin. [0004] US Patent No. 5,196,444 discloses the curative effect of candesartan cilexetil in treating hypertension, and discloses a crystal form of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K47/10A61K47/38A61K31/4184A61P9/12
CPCA61K9/2031A61K9/2054A61K9/2095A61K31/4184A61P9/12
Inventor 丁强曾清泉金波宋志林高玉贺程雪清王衡新
Owner HINYE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products